Efficacy/Safety of Imprime PGG® Injection With Cetuximab and Paclitaxel/Carboplatin Therapy in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)
| Status: | Archived |
|---|---|
| Conditions: | Lung Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | August 2009 |
| End Date: | December 2011 |
Efficacy and Safety Study of Imprime PGG® Injection in Combination With Cetuximab and Concomitant Paclitaxel and Carboplatin Therapy in Patients With Previously Untreated Advanced (Stage IIIB or IV) Non-Small Cell Lung Cancer
The Phase 2 study described in this protocol will serve to evaluate the antitumor activity,
safety and pharmacokinetic profile of Imprime PGG when combined with cetuximab and
concomitant paclitaxel and carboplatin therapy in patients with previously untreated
advanced NSCLC. Additionally, this study will provide guidance for the design of more
definitive efficacy studies of Imprime PGG in NSCLC patients.
We found this trial at
5
sites
2450 Riverside Avenue
Minneapolis, Minnesota 55455
Minneapolis, Minnesota 55455
(612) 273-3000
University of Minnesota Medical Center Improving patients' lives drives the innovation that makes University of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Med College of Georgia Georgia Regents University, home of the Medical College of Georgia, is...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials